Ovarian cancer is the fifth most common cancer in women and the second most common gynecologic cancer, second to breast cancer and accounts for 4% of all cancers in women.

A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight, indicating that obesity may contribute to the development of ovarian cancer through a hormonal mechanism.

Ovarian cancer has the highest mortality rate of all the female cancers, primarily because it produces few early-warning signs and is, therefore, often detected late.

About 70 percent of women have advanced disease at the time of diagnosis. Ovarian cancer has a 5-year survival rate of only 37 percent. While studies have linked excess body weight to higher risks of certain cancers, little is known about the relationship between body mass index and ovarian cancer risk.

To investigate this issue, Dr. Michael F. Leitzmann of the National Cancer Institute and colleagues studied 94,525 U.S. women aged 50 to 71 years over a period of seven years. The researchers documented 303 ovarian cancer cases during this time and noted that among women who had never taken hormones after menopause, obesity was associated with an almost 80 percent higher risk of ovarian cancer. In contrast, no link between body weight and ovarian cancer was evident for women who had ever used menopausal hormone therapy.

According to Dr. Leitzmann, these findings support the hypothesis that obesity may enhance ovarian cancer risk in part through its hormonal effects. Excess body mass in postmenopausal women leads to an increased production of estrogen, which in turn may stimulate the growth of ovarian cells and play a role in the development of ovarian cancer.

Among women with no family history of ovarian cancer, obesity and increased ovarian cancer risk were also linked in this study. However, women that did have a positive family history of ovarian cancer showed no association between body mass and ovarian cancer risk.

These latest findings provide important additional information related to women's risks of developing ovarian cancer. "The observed relations between obesity and ovarian cancer risk have relevance for public health programs aimed at reducing obesity in the population," the authors wrote.

Related Articles


Accurate New Ovarian Cancer Test Uses a Single Drop of Blood Scientists have attained very promising results on their initial investigations of a new test for ovarian cancer. Using a new technique involving mass spectrometry of a

UVA Radiation Damages DNA in Skin Cells That Can Lead to Melanoma A study has found that UVA radiation damages the DNA in human melanocyte cells, causing mutations that can lead to melanoma.

Papaya Extract Has Anti Cancer Effect Against Lab Grown Tumors The humble papaya is gaining credibility in Western medicine for anticancer powers that folk cultures have recognized for

Peach and Plum Extracts Kill Aggressive Breast Cancer Cells Breast cancer cells - even the most aggressive type - died after treatments with peach and plum extracts in lab tests at Texas AgriLife Research recently, and scientists say the results are

Incidence of Colon Cancer Increasing in Young Adults Colon cancer (colorectal cancer) is the fourth most common malignant neoplasm worldwide and the second leading cause of cancer deaths (irrespective of gender) in the

References:
1. Michael F. Leitzmann, Corinna Koebnick, Kim N. Danforth, Louise A. Brinton, Steven C. Moore, Albert R. Hollenbeck, Arthur Schatzkin, and James V. Lacey. Body mass index and risk of ovarian cancer. Jr. CANCER. January 05, 2009 (DOI: 10.1002/cncr.24086).
2. National Cancer Institute.
2. Image from massdistraction

Add comment

User Name (Required)

E-mail (Required - Never shown publicly)

Website (Optional)

Notify me of follow-up comments

If you cannot read the code click to refresh for a new code.

Add comment

Cancel